MoonLake CEO Jorge Santos da Silva sells $2.05 million of common shares

• MoonLake Immunotherapeutics CEO Jorge Santos da Silva sold 102,225 Class A ordinary shares on July 9-10.
• Sales priced at USD 20.01 per share on July 9, USD 20.02 per share on July 10.
• Direct holdings fell to 2,774,893 Class A ordinary shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moonlake Immunotherapeutics published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-077564), on July 13, 2026, and is solely responsible for the information contained therein.